Dianthus Therapeutics (DNTH) Cash from Investing Activities (QoQ) (2017 - 2025)
Dianthus Therapeutics (DNTH) Cash from Investing Activities (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -861.11% |
| Jun 30, 2025 | 78.75% |
| Mar 31, 2025 | 164.02% |
| Dec 31, 2024 | 91.09% |
| Sep 30, 2024 | -22,286.83% |
| Jun 30, 2024 | 121.23% |
| Mar 31, 2024 | 33.14% |
| Dec 31, 2023 | 28.41% |
| Sep 30, 2023 | -152.62% |
| Jun 30, 2023 | 20.59% |
| Mar 31, 2023 | 243.16% |
| Dec 31, 2022 | -84.06% |
| Sep 30, 2022 | -5,234.11% |
| Jun 30, 2022 | 99.68% |
| Mar 31, 2022 | -288.88% |
| Dec 31, 2021 | -163.06% |
| Sep 30, 2021 | -45.23% |
| Jun 30, 2021 | 298.89% |
| Mar 31, 2021 | 110.56% |
| Dec 31, 2020 | -455.23% |